AHK-Cu Research: ATCUN Copper Chemistry and Comparative Peptide Pharmacology

AHK-Cu (Ala-His-Lys copper complex) is a synthetic tripeptide incorporating Cu(II) coordinated through the ATCUN (Amino Terminal Copper and Nickel) binding motif. Structurally related to GHK-Cu (Gly-His-Lys copper complex), AHK-Cu provides a direct pharmacological comparator for investigating the role of the N-terminal amino acid in ATCUN copper coordination chemistry and downstream biological activity.

The ATCUN Motif and Copper Coordination

The ATCUN (Amino Terminal Copper and Nickel) motif is defined by the sequence X-X-His at the N-terminus of a peptide, where the first two positions can be any amino acid but histidine must occupy position 3. Cu(II) is coordinated in a square planar geometry by four nitrogen donors: the N-terminal primary amine, the deprotonated amide nitrogen between residues 1 and 2, the deprotonated amide nitrogen between residues 2 and 3, and the imidazole nitrogen of His3. This square planar N4 coordination is highly stable (stability constant log K approximately 16 for GHK-Cu) and produces the characteristic blue-green colour of ATCUN-Cu complexes through Cu(II) d-d electronic transitions in the visible spectrum.

Both GHK (Gly-His-Lys) and AHK (Ala-His-Lys) satisfy the ATCUN requirement — His at position 3, free N-terminus. The structural difference is solely at position 1: glycine (H side chain, achiral) versus alanine (methyl side chain, chiral L-configuration). This single methyl group addition introduces steric bulk adjacent to the N-terminal coordination site, potentially altering the geometry of copper coordination and the resulting EPR and UV-visible spectroscopic signature.

Copper Coordination Chemistry Research

EPR Spectroscopy: The definitive characterisation of ATCUN copper coordination uses X-band EPR (9.5 GHz, 77K or liquid helium temperature for frozen solutions). Square planar Cu(II) in ATCUN complexes shows an axial spectrum with g-parallel approximately 2.18-2.22 and four-line copper hyperfine splitting (A-parallel approximately 180-200 × 10^-4 cm^-1). Comparing EPR parameters between GHK-Cu and AHK-Cu directly quantifies how the Gly1→Ala1 substitution affects Cu(II) coordination geometry. Any change in A-parallel indicates a change in the equatorial donor set geometry that may affect copper's redox chemistry.

UV-Visible Spectroscopy: Both GHK-Cu and AHK-Cu should show d-d transition absorption bands between 600-700nm. Prepare equimolar solutions (1-5mM) in 50mM HEPES pH 7.4. Scan 400-900nm. Compare lambda-max and extinction coefficient between the two complexes — a shift in lambda-max indicates a change in ligand field strength attributable to the N-terminal residue difference.

Cyclic Voltammetry: The Cu(II)/Cu(I) redox potential of ATCUN complexes is pharmacologically important — lower reduction potential means more stable Cu(II), less likely to undergo Fenton chemistry. Compare CV traces for GHK-Cu and AHK-Cu in phosphate buffer pH 7.4 using a glassy carbon working electrode. The half-wave potential difference (if any) characterises whether the Ala1 versus Gly1 difference affects copper redox chemistry.

Stability Constant Determination: Competitive chelation against a reference ligand of known stability constant (e.g., nitrilotriacetic acid, NTA) allows indirect determination of AHK-Cu stability constant by UV-vis monitoring of the competition equilibrium. Compare with published GHK-Cu stability constant (log K approximately 16.2) to quantify the effect of the N-terminal amino acid on overall copper binding affinity.

Comparative Biological Research

Fibroblast collagen synthesis: Primary human dermal fibroblasts in DMEM + 10% FBS. Four treatment groups: vehicle, GHK-Cu (0.1-100nM), AHK-Cu (0.1-100nM), CuSO4 alone (matching copper concentration). 72-hour treatment. Measure procollagen type I C-propeptide (PICP) by ELISA in conditioned medium and COL1A1/COL1A2 mRNA by RT-PCR. Any difference in collagen synthesis between GHK-Cu and AHK-Cu at matched copper concentrations is attributable to the peptide sequence difference (Gly versus Ala at position 1).

SP1 transcription factor activation: GHK (and by extension GHK-Cu) has been proposed to activate SP1 transcription factor, driving expression of growth factors and ECM proteins. SP1-responsive luciferase reporter assay in fibroblasts (transiently transfected with 3×SP1-pGL3) comparing GHK-Cu and AHK-Cu at matched concentrations characterises whether SP1 activation is Gly1-specific or is a shared ATCUN property.

Wound healing scratch assay: Confluent fibroblast monolayers, scratch with sterile pipette tip, treat with GHK-Cu or AHK-Cu (0.1-100nM) in serum-free medium. Image at 0, 12, and 24 hours. Measure wound area by automated image analysis. Compare migration rate between treatments.

Key Published Research

• Pickart L, Vasquez-Soltero JM, Margolina A. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." BioMed Research International, 2015. PMID: 25883971
• Camponeschi F, et al. "Metal binding properties of short peptides based on the ATCUN motif." Inorganic Chemistry, 2013.
• Harford C, Sarkar B. "Amino terminal Cu(II)- and Ni(II)-binding (ATCUN) motif of proteins and peptides." Accounts of Chemical Research, 1997. PMID: 9276864

View AHK-Cu (Copper Tripeptide) →

For laboratory and analytical research purposes only. Not for human or veterinary use.